Comparing Cosmos Group (OTCMKTS:COSG) & MDB Capital (NASDAQ:MDBH)

Insider and Institutional Ownership

0.4% of MDB Capital shares are owned by institutional investors. 0.4% of Cosmos Group shares are owned by company insiders. Comparatively, 55.5% of MDB Capital shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Cosmos Group has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, MDB Capital has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Profitability

This table compares Cosmos Group and MDB Capital’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cosmos Group	N/A	N/A	-78.39%
MDB Capital	N/A	-75.31%	-63.59%

Valuation and Earnings

This table compares Cosmos Group and MDB Capital”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Group	$620,000.00	0.74	-$77.34 million	N/A	N/A
MDB Capital	$5.99 million	10.71	-$6.97 million	($2.87)	-2.40

MDB Capital has higher revenue and earnings than Cosmos Group.

Summary

MDB Capital beats Cosmos Group on 6 of the 8 factors compared between the two stocks.

About Cosmos Group

Cosmos Group Holdings Inc. focuses on the physical artworks and collectibles business in Hong Kong and internationally. It operates online platform to sell and distribute the arts and collectibles to end-users with the use of blockchain technologies and minting tokens. The company is based in Singapore.

About MDB Capital

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.